BIOTECHNOLOGY VALUE FUND L P - 20 Nov 2025 SCHEDULE 13D/A Report for Repare Therapeutics Inc. Common Shares, no par value (RPTX)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Repare Therapeutics Inc. Common Shares, no par value
Symbol
RPTX
Shares outstanding
43,056,667 shares
Disclosed Ownership
10,333,600 shares
Ownership
24%
Form type
SCHEDULE 13D/A
Filing time
24 Nov 2025, 17:05:05 UTC
Date of event
20 Nov 2025
Next filing
30 Jan 2026
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 12% 5,309,432 0 5,309,432 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0000918923
BVF I GP LLC 12% 5,309,432 0 5,309,432 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803805
BIOTECHNOLOGY VALUE FUND II LP 10% 4,308,573 0 4,308,573 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001102444
BVF II GP LLC 10% 4,308,573 0 4,308,573 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803806
Biotechnology Value Trading Fund OS LP 1.3% 548,938 0 548,938 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660683
BVF Partners OS Ltd. 1.3% 548,938 0 548,938 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001660684
BVF GP HOLDINGS LLC 22% 9,618,005 0 9,618,005 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001803809
BVF PARTNERS L P/IL 24% 10,333,600 0 10,333,600 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001055947
BVF INC/IL 24% 10,333,600 0 10,333,600 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory 0001056807
LAMPERT MARK N 24% 10,333,600 0 10,333,600 /s/ Mark N. Lampert Mark N. Lampert 0001233840